Alexion Pharmaceuticals
Alexion Pharmaceuticals, Inc.
121 Seaport Blvd
Boston, MA 02210
Phone: 1-475-230-2596Website: https://alexion.com/Careers: alexion.com/your-career...Patient Assistance Program: alexion.com/our-medicines...
Latest news
- Ultomiris Approved in the US for Adults with Generalised Myasthenia Gravis
28 April 2022 - Alexion Announces FDA Approval of Ultomiris (ravulizumab-cwvz) for Children and Adolescents with Paroxysmal Nocturnal Hemoglobinuria (PNH)
7 June 2021 - Alexion Receives FDA Approval for New Advanced Formulation of Ultomiris (ravulizumab-cwvz) with Significantly Reduced Infusion Time
12 October 2020 - Alexion Receives FDA Approval for Ultomiris (ravulizumab-cwvz) for Atypical Hemolytic Uremic Syndrome (AHUS)
18 October 2019 - FDA Approves Ultomiris (ravulizumab-cwvz) for Adults with Paroxysmal Nocturnal Hemoglobinuria (PNH)
21 December 2018 - Alexion Submits Application for Priority Review and Approval of ALXN1210 as a Treatment for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) in the U.S.
19 June 2018 - FDA Approves Kanuma (sebelipase alfa) for Lysosomal Acid Lipase Deficiency
8 December 2015 - FDA Approves Strensiq (asfotase alfa) for Perinatal, Infantile and Juvenile-Onset Hypophosphatasia
23 October 2015 - Alexion Receives Notification of PDUFA Date Extension for Kanuma (sebelipase alfa)
6 September 2015 - Alexion Completes Rolling BLA Submission to FDA for Asfotase Alfa for Hypophosphatasia
30 December 2014
Drugs Associated with Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. manufactures, markets and/or distributes more than 4 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
Kanuma
Generic name: sebelipase alfa Drug class: lysosomal enzymes |
||
|
Soliris
Generic name: eculizumab Drug class: selective immunosuppressants |
1 review | 5.0 / 10 |
|
Strensiq
Generic name: asfotase alfa Drug class: miscellaneous metabolic agents |
||
|
Ultomiris
Generic name: ravulizumab Drug class: selective immunosuppressants |
2 reviews | 10 / 10 |
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||